EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from …
…, HG van der Poel, GJLH van Leenders… - European urology, 2019 - Elsevier
… GJLA van Leenders has served on the advisory board for Roche, and received company
speaker honorarium from Astellas and research grants from Roche and AstraZeneca. Professor …
speaker honorarium from Astellas and research grants from Roche and AstraZeneca. Professor …
Raman spectroscopy for cancer detection and cancer surgery guidance: translation to the clinics
…, CHM van Deurzen, LB Koppert, GJLH van Leenders… - Analyst, 2017 - pubs.rsc.org
Oncological applications of Raman spectroscopy have been contemplated, pursued, and
developed at academic level for at least 25 years. Published studies aim to detect pre-…
developed at academic level for at least 25 years. Published studies aim to detect pre-…
Epithelial cell differentiation in the human prostate epithelium: implications for the pathogenesis and therapy of prostate cancer
GJLH Van Leenders, JA Schalken - Critical reviews in oncology …, 2003 - Elsevier
Within the human prostate epithelium four cell populations are discriminated by their
expression of keratins (K). While basal cells co-localize K5 and K14 combined with low levels of …
expression of keratins (K). While basal cells co-localize K5 and K14 combined with low levels of …
[HTML][HTML] The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma
GJLH Van Leenders, TH Van Der Kwast… - The American journal …, 2020 - journals.lww.com
Five years after the last prostatic carcinoma grading consensus conference of the International
Society of Urological Pathology (ISUP), accrual of new data and modification of clinical …
Society of Urological Pathology (ISUP), accrual of new data and modification of clinical …
Cadherin switching in human prostate cancer progression
K Tomita, A van Bokhoven, GJLH van Leenders… - Cancer research, 2000 - AACR
The progression of carcinomas is associated with the loss of epithelial morphology and a
concomitant acquisition of a more mesenchymal phenotype, which in turn is thought to …
concomitant acquisition of a more mesenchymal phenotype, which in turn is thought to …
Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging
…, GJLH van Leenders, CA Hulsbergen-Van De Kaa… - Radiology, 2003 - pubs.rsna.org
PURPOSE: To evaluate which parameters of dynamic magnetic resonance (MR) imaging
and T2 relaxation rate would result in optimal discrimination of prostatic carcinoma from …
and T2 relaxation rate would result in optimal discrimination of prostatic carcinoma from …
Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer
…, WD Heemsbergen, GJLH van Leenders… - International Journal of …, 2008 - Elsevier
PURPOSE: To update the analysis of the Dutch dose-escalation trial of radiotherapy for
prostate cancer. PATIENTS AND METHODS: A total of 669 patients with localized prostate …
prostate cancer. PATIENTS AND METHODS: A total of 669 patients with localized prostate …
[HTML][HTML] Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients
…, EPM Corssmit, GJ Van Leenders… - The American journal …, 2014 - journals.lww.com
Succinate dehydrogenase (SDH)-deficient renal carcinoma has been accepted as a provisional
entity in the 2013 International Society of Urological Pathology Vancouver Classification…
entity in the 2013 International Society of Urological Pathology Vancouver Classification…
[HTML][HTML] Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer
…, CH Bangma, TH Van Der Kwast, GJ Van Leenders - Modern pathology, 2015 - Elsevier
Patients with Gleason score 7 prostate cancer on radical prostatectomy demonstrate a wide
range in clinical outcome. Gleason grade 4 prostate cancer encompasses a heterogeneous …
range in clinical outcome. Gleason grade 4 prostate cancer encompasses a heterogeneous …
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial
…, RF Hoedemaeker, GJLH van Leenders… - The Journal of …, 2011 - auajournals.org
Purpose : The identification of clinically insignificant prostate cancer could help avoid
overtreatment. Current criteria for insignificant prostate cancer use a tumor volume threshold of …
overtreatment. Current criteria for insignificant prostate cancer use a tumor volume threshold of …